Long-Term Outcome of Myocardial Protection in Heart Transplantation: Comparison Among 3 Different Solutions
Interdisciplinary CardioVascular and Thoracic Surgery · 2026
DOI: 10.1093/icvts/ivaf301 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, 2026. Verfasst von Fabrizio Settepani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Surgery and Heart Transplant Unit, Cardio-Thoraco-Vascular Department, ASST Grande Ospedale Metropolitano Niguarda: Azienda Socio Sanitaria T…. Hauptthemen laut MEDLINE: Heart Transplantation, Primary Graft Dysfunction, Cardioplegic Solutions, Heart Arrest, Induced. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
We analysed our long-term experience with heart transplantation (Htx) utilizing 3 different cardioplegic solutions.
Methods
During a 20-year period, 538 adult individuals underwent isolated Htx at our institution. Ten cases in which the Organ Care System TransMedics Inc was utilized were excluded, resulting in a final cohort of 528 individuals. Patients were stratified into 3 groups according to the donor heart cardioplegic solution: Celsior (n = 301; reference group), HTK-Custodiol (n = 88), and St Thomas (n = 139). Mean follow-up period was 6.2 ± 5.5 years (maximum 20 years).
Results
The rate of severe primary graft dysfunction (PGD) was 10.2% in the HTK-Custodiol group, significantly higher than the reference group (4.5%; P < .040). Overall, in-hospital mortality was 12.9%: 13.6% in the HTK-Custodiol group and 12.9% in the St Thomas group, comparable to the reference group (P = .803 and P = .924). Survival at 1, 5, and 12 years in the Celsior and HTK-Custodiol groups was 82.6 ± 2.2% vs 85.2±3.8%, 79.4 ± 2.4% vs 82.1 ± 4.3%, and 66.8 ± 3.3% vs 62.9 ± 7.3%, respectively (P = .706). Survival at 1, 5, and 12 years in the St Tomas group was 81.5 ± 3.4%, 71.9 ± 4.1%, and 65.5 ± 5.2%, respectively, comparable to the reference group (P = .640). Post-transplant rejection rate was similar among the groups.
Conclusions
The use of HTK-Custodiol solution was associated with a significantly higher incidence of PGD when compared to Celsior solution, although this data had no impact on in-hospital mortality. Long-term survival and post-transplant rejection were comparable among the 3 groups. HTK-Custodiol solution should be used with caution for preservation of donor hearts. ERB Approval Number 215-29042020; May 5, 2020.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiac Surgery and Heart Transplant Unit, Cardio-Thoraco-Vascular Department, ASST Grande Ospedale Metropolitano Niguarda: Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, 20162, Ital…
- Intensive Care Unit, Cardio-Thoraco-Vascular Department, ASST Grande Ospedale Metropolitano Niguarda: Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, 20162, Italy.
- Cardiology 2 Unit, Cardio-Thoraco-Vascular Department, ASST Grande Ospedale Metropolitano Niguarda: Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, 20162, Italy.
ORCID-Profile: Fabrizio Settepani
Zitieren
APA
Settepani, F., Cannata, A., Belluschi, I., Pisani, G. P., Mondino, M. G., Garascia, A., & Russo, C. F. (2026). Long-Term Outcome of Myocardial Protection in Heart Transplantation: Comparison Among 3 Different Solutions. Interdisciplinary CardioVascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivaf301
Vancouver
Settepani F, Cannata A, Belluschi I, Pisani GP, Mondino MG, Garascia A, et al. Long-Term Outcome of Myocardial Protection in Heart Transplantation: Comparison Among 3 Different Solutions. Interdisciplinary CardioVascular and Thoracic Surgery. 2026. doi:10.1093/icvts/ivaf301
BibTeX
@article{Settepani2026,
author = {Settepani, Fabrizio and Cannata, Aldo and Belluschi, Igor and Pisani, Giulia Pinuccia and Mondino, Michele Giovanni and Garascia, Andrea and Russo, Claudio Francesco},
title = {Long-Term Outcome of Myocardial Protection in Heart Transplantation: Comparison Among 3 Different Solutions},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2026},
doi = {10.1093/icvts/ivaf301}
}
EUVIMED